SURVEY ACTIVITY SUSPENDED

In response to the threat posed by the spread of COVID-19, CMS has called for a suspension of most state agency and accrediting organization survey activities for the indefinite future. HFAP surveys that WILL go forward include: Incoming immediate jeopardy complaints alleging infection control breaches or abuse and neglect. Complaint Surveys (lower level than immediate…

Read more

Lab Notification: Laboratory Biosafety COVID-19 FAQ

Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services Please note the CDC’s COVID-19 Information for Laboratories web page was updated on March 2, 2020. This revision includes an update to the Laboratory Biosafety Frequently Asked Questions (FAQs) to clarify practices for working inside a BSC and additional FAQs.…

Read more

Lab Notification: COVID-19 Diagnostic Testing Advisory

Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for the CDC 2019-Novel Coronavirus (COVID-19) Real-Time RT-PCR Diagnostic Panel which is to be used in qualified laboratories for testing patient respiratory specimens that meet CDC criteria for…

Read more

Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with 2019 Novel Coronavirus (2019-nCoV)

Attention: Clinical Laboratories, Acute Care Hospitals, Critical Access Hospitals Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services Please note that the “Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with 2019 Novel Coronavirus (2019-nCoV)” was updated on February 10, 2020. The revisions include: The term “certified”…

Read more